El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

By B. Brooks, Robert G. Miller, M. Swash, T. Munsat. Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders, 2000

5,298 citations recorded by the source corpus.

Subfields: Neurology

View Paper: https://www.semanticscholar.org/paper/4bdb73fc5f6442765ef22d0415451579cc5b28d4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Pegah Masrori
2. P. van Damme
3. Alan Connelly
4. Jacques-Donald Tournier

Citations in the corpus

• The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study (2011, methodology): “9 All recruited patients met the criteria for possible, probable or definite ALS as defined by the El Escorial diagnostic criteria for ALS.(10) Exclusion criteria included history of other neurologic conditions that could affect cognition (major hemispheric stroke, traumatic brain injury, learning d”
• A comprehensive review of amyotrophic lateral sclerosis (2015, methodology): “Criteria and requirements for diagnosis The El Escorial criteria for diagnosing ALS was published in 1994 by the World Federation of Neurology for inclusion standards for patients entering research studies and clinical trials.[3,35] The importance of laboratory exams as diagnostic tools to exclude d”
• Apparent Fibre Density: A novel measure for the analysis of diffusion-weighted magnetic resonance images (2012, methodology): “Twenty-one patients with probable or definite MND, as defined by the revised EL Escorial criteria (Brooks et al., 2000), were recruited into the study.”
• Amyotrophic lateral sclerosis: a clinical review (2020, background): “tials in relaxed muscles and chronic neurogenic changes upon contraction) [8,69].”
• Connectivity-based fixel enhancement: Whole-brain statistical analysis of diffusion MRI measures in the presence of crossing fibres (2015, methodology): “We acquired data from 24 healthy control subjects and 24 patients with probable or de fi nite MND, as de fi ned by the revised El Escorial criteria (Brooks et al., 2000).”